Olympia Pharmacy Recalls Bi Mix Due to Sterility Concerns
Olympia Pharmacy is recalling Bi Mix compounded in Orlando, FL, due to FDA inspection findings regarding quality control and lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant risks such as sterility failures in compounded drugs are categorized as Severe (Score 4), particularly when no specific hospitalization reports are cited to elevate it to Critical.
Plain-English summary
Lowlite Investments, Inc. D/B/A Olympia Pharmacy is recalling four units of Bi Mix compounded in Orlando, Florida. The recall was initiated following FDA inspection findings that raised concerns regarding the quality control processes used during the compounding of the product.
The specific hazard identified is a lack of assurance of sterility. The affected products were distributed nationwide and to Puerto Rico. The recall includes specific lot codes: A5028 (Exp 6/2/13), B5011 (Exp 6/1/13), C4112 (Exp 6/1/13), and C4208 (Exp 6/20/13).
Consumers who have purchased these specific lots of Bi Mix should stop using the product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Bi mix, compounded by Olympia Pharmacy, Orlando, FL
- Manufacturer
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Category
- Drug — Compounded Drug
- Affected units
- 4
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- A5028 Exp 6/2/13
- B5011 exp 6/1/13
- C4112 Exp 6/1/13
- and C4208 Exp 6/20/13
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 105 recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 105 products in this recall →Related recalls
Same manufacturer · Lowlite Investments, Inc. D/B/A Olympia Pharmacy
See all →- SevereOlympia Pharmacy Recalls Diclazuril Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- HighOlympia Pharmacy Recalls Metabolase Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls Betamethasone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
- SevereOlympia Pharmacy Recalls HACC 270.1 Injection Due to Sterility Concerns
FDA (Drugs) · 2013-07-17
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- HighPharmaceutical Diluent Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Phenylephrine 1 mg/mL Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Olympia Mineral Blend Injectable for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighSermorelin Acetate Injection Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2022-06-01
- HighPyridoxine Injection Vials Recalled by FDA Due to Sterility Failure
FDA (Drugs) · 2022-06-01
- HighAlpha Lipoic Acid injection vials recalled for sterility assurance defect
FDA (Drugs) · 2022-06-01